Literature DB >> 30444060

Cytotoxic Neo-Clerodane Diterpenoids from Scutellaria barbata D.Don.

Maolin Wang1, Chenyao Ma1, Yong Chen2, Xiang Li1,2, Jianwei Chen1,2.   

Abstract

A new neo-clerodane diterpenoid, barbatin H (1), together with fifteen known analogues (2-16) were isolated from Scutellaria barbata D.Don. Their structures were determined on the basis of NMR and HR-MS spectral analysis and comparison with the reported data. All of those compounds were comparatively predicted for their cytotoxic activities against four human tumor cell lines, i. e. LoVo (colon cancer), MCF-7 (breast cancer), SMMC-7721 (hepatoma cancer), and HCT-116 (colon cancer) cells by MTT method in vitro. The results turned out that the series of neo-clerodane diterpenoids exhibited varying degrees of cytotoxic activities against the growth of the tested tumor cell lines, and most of them exhibited selective cytotoxicity against LoVo cell lines. Scutebata A (14) showed significant cytotoxic activities against four tested tumor cells with IC50 values of 4.57, 7.68, 5.31, and 6.23 μm, respectively, which indicated that it might be a potential chemotherapeutic agent.
© 2019 Wiley-VHCA AG, Zurich, Switzerland.

Entities:  

Keywords:  Scutellaria barbata; cytotoxicity; neo-clerodane diterpenoids; phytochemistry; structure elucidation

Mesh:

Substances:

Year:  2019        PMID: 30444060     DOI: 10.1002/cbdv.201800499

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  4 in total

1.  Anticancer Activity of Modified Tongyou Decoction on Eca109 Esophageal Cancer Cell Invasion and Metastasis through Regulation of the Epithelial-Mesenchymal Transition Mediated by the HIF-1α-Snail Axis.

Authors:  Yongsen Jia; Xin Yan; Ying Cao; Wei Song; Guangji Zhang; Xueqin Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-29       Impact factor: 2.629

2.  Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking.

Authors:  Xiangjun Qi; Hongbin Xu; Peng Zhang; Guoming Chen; Zhiqiang Chen; Caishan Fang; Lizhu Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

3.  Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification.

Authors:  Hongjian Shi; Jie Liu; Jingying Fan; Lan He; Xianwen Wang; Faqing Tang; Daofa Tian; Yingchun He
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-07       Impact factor: 2.629

4.  Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Authors:  Sheng-Teng Huang; Yeh Chen; Wei-Chao Chang; Hsiao-Fan Chen; Hsiang-Chun Lai; Yu-Chun Lin; Wei-Jan Wang; Yu-Chuan Wang; Chia-Shin Yang; Shao-Chun Wang; Mien-Chie Hung
Journal:  Viruses       Date:  2021-05-02       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.